NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
08/08/2023
Voltar para busca
Dado oficial do USPTO
D'PULA MEDICAL SOLUTIONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
D'PULA MEDICAL SOLUTIONS
ST13
US500000088907215Classe
9, 35, 42, 45
Pedido
88907215
Registro
6932929
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
08/08/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 42, 45
Data de depósito
08/05/2020
Data de registro
27/12/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/12/2022
Última transação
06/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Hyogo, JP
Examinador
CHANG, KATHERINE S
Unidade examinadora
M60
Localização atual
TMO LAW OFFICE 115
Titulares e representantes
Titulares
D'Pula Medical Solutions Corporation
S. C. (pessoa física)
Representantes
Jonathan Brown CROWELL & MORING
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Recorded and downloadable computer software platforms for executing medical application softwarefor providing of medical information to medical organizationspotential patientspatients or medical professionals; Downloadable computer application software for providing of medical information to medical organizationsmedical providerspotential patientspatients or medical professionals; Downloadable computer application software for medical treatmentfor digital therapeutics; Downloadable computer application software for medical testing and diagnostics
Classe 35
Business consultancy services; Providing business information; Business consultancy services relating to pharmaceutical application in the nature of regulatory submission managementassisting others in preparing or filing applications for regulatory approval of pharmaceuticalsmedical devices or medical software; Providing business information relating to pharmaceutical applicationinformation on regulatory submission management regarding the preparation or filing of applications for regulatory approval of pharmaceuticalsmedical devices or medical software as it relates to business; Business consultancy services in the field of pharmaceuticals; Providing business information in the field of pharmaceuticals
Classe 42
Platform as a service (PaaS) featuring computer software platforms for executing medical application softwarefor providing of medical information to medical organizationsmedical providerspotential patientspatients or medical professionals; Designdevelopment and maintenance of computer software platforms; Providing temporary use of online non-downloadable computer software for providing of medical information to medical organizationsmedical providerspotential patientspatients or medical professionals; Designdevelopment and maintenance of computer application software; Providing temporary use of online non-downloadable computer software for medical treatmentfor digital therapeutics; Providing temporary use of online non-downloadable computer software for medical testing and diagnostics; Designdevelopment and maintenance of computer application software for medical treatment; Designdevelopment and maintenance of computer application software for medical testing and diagnostics
Classe 45
Regulatory compliance consulting in the field of assisting others in preparing or filing pharmaceutical applications for regulatory approval of pharmaceuticalsmedical devices or medical software
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
06/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/07/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
27/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
27/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2022
PUBO
PUBLISHED FOR OPPOSITION
11/10/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
28/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/09/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/09/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/08/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/08/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/08/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/07/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/01/2022
GNRT
NON-FINAL ACTION E-MAILED
26/01/2022
CNRT
NON-FINAL ACTION WRITTEN
26/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/01/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/01/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
20/09/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
30/08/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
30/08/2021
CNSI
SUSPENSION INQUIRY WRITTEN
30/08/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
25/02/2021
GNSL
LETTER OF SUSPENSION E-MAILED
25/02/2021
CNSL
SUSPENSION LETTER WRITTEN
25/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/02/2021
ALIE
ASSIGNED TO LIE
17/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/06/2020
GNRT
NON-FINAL ACTION E-MAILED
03/06/2020
CNRT
NON-FINAL ACTION WRITTEN
03/06/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
28/05/2020
DOCK
ASSIGNED TO EXAMINER
26/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/05/2020
NWAP
NEW APPLICATION ENTERED
12/05/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace D'PULA MEDICAL SOLUTIONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.